US › Healthcare

Phibro Animal Health Corporation (PAHC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$36.59-1.51%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$383.5M
Revenue YoY
+10.3%
Net profit
$24.0M
Profit YoY
+15.1%
EPS
$0.76
EPS estimate
$0.71
Net margin
6.3%

EPS came in at 0.76 against a street estimate of 0.71 — a beat of 7.0%.

Key statistics

Market cap
$1.51B
P/E
15.9
Forward P/E
13.8
P/B
4.08
Book value
$8.92
EPS (TTM)
$2.33
Dividend yield
1.32%
52-week high
$59.83
52-week low
$25.76
50-day MA
$32.75
200-day MA
$42.63
Beta
0.46

Analyst view

Analysts rate Phibro Animal Health Corporation a hold (0 buy, 2 hold, 2 sell out of 4) with an average price target of $45.00.

Shareholding

Insiders
0.85%
Institutions
100.02%

Largest institutional holders

FundStake
BlackRock Inc8.02%
FMR Inc5.36%
Vanguard Group Inc3.80%
State Street Corp2.34%
Vanguard Capital Management, LLC2.20%
Acadian Asset Management LLC1.52%
Geode Capital Management, LLC1.49%
Renaissance Technologies Corp1.42%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Phibro Animal Health Corporation — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.